Companies and laboratories

The company objective is:

• the development, production, marketing, research and preclinical valation of new markers cancer and monoclonal antibodies for the development of anti-cancer therapies
• the selection of therapeutic targets and monoclonal antibodies capable of binding the tumor cells of colon, ovar and breast, with property in vitro and in vivo therapeutics and which are the subject of the available patients

The company also carries out activities in the field of biotechnology, online platforms, mobile applications or other web tools in the biotechnological and medical R&D sector.